Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats

Takahara, Terumi, Furui, Kei, Funaki, Jun, Nakayama, Yoshihide, Itoh, Hiroyuki, Miyabayashi, Chiharu, Sato, Hiroshi, Seiki, Motoharu, Ooshima, Akira, Watanabe, Akiharu · 1995 · Hepatology

Abstract

Matrix metalloproteinase-II (MMP-II, 72-kd type IV collagenase, or gelatinase) is one of the gene families of zinc enzymes capable of degrading extracellular matrix molecules, and specifically of degrading type IV and V collagens, gelatin, fibronectin, and elastin. In this study, we used both the liver fibrosis model and the reversibility model of experimental cirrhosis to clarify how MMP-II participates in liver fibrosis of rats. To produce fibrosis model, rats received subcutaneous injections of CCI 4 twice weekly for 7, 9, or 14 weeks. For the reversibility model, rats were treated with CCl 4 three a week for 8 weeks and killed at 3, 7, 14, 28, or 42 days after discontinuation of treatment. MMP-II gene expression was studied by Northern hybridization technique, and gelatinase activity of MMP-II was examined by zymography using gelatin substrate. At the same time, an immunohistochemical study using anti-type IV collagen antibody was carried out. In liver fibrosis model, nodule formation was established at 14 weeks. Immunodeposit of type IV collagen was increased in wide fibrous septa and was clearly observed along sinusoidal wall. Gene expression of MMP-II increased up to 7 to 12 times compared with that of controls, with the expression rate being maximum at an intermediate stage of fibrosis. Zymography showed the expressions of both 65-kd latent MMP-II, which is confirmed to be activated by adding p-aminophenylmercuric acetate, and 62-kd active MMP-II during fibrosis. The expression of both forms increased 13 to 28 times as the fibrosis progressed. By contrast, little latent MMP-II was detected in control livers. The percent active form to total MMP-II at each stage was elevated most at an intermediate stage of fibrosis up to 30% and decreased to 16% in the cirrhotic stage. As cirrhosis reversed, fibrous septa became thin but still persisted at 42 days in the reversibility model. Immunostaining of type IV collagen was increased in thin septa and faintly observed along sinusoid. Gene expression was elevated 18-fold and recovered gradually to remain elevated 18-fold and recovered gradually to remain elevated at 42 days after the discontinuation of intoxication. Expressions of both active and latent forms detected by zymography were elevated 15-fold during the early reversible stage and decreased gradually after the discontinuation of intoxication. These results indicated MMP-II may participate in pathogenesis of liver fibrosis and cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.1840210328

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 168

Metadata

Authors
Takahara, T., Furui, K., Funaki, J., Nakayama, Y., Itoh, H., Miyabayashi, C., Sato, H., Seiki, M., Ooshima, A., & Watanabe, A.
Venue
Hepatology
Published
1995-03
Volume
21
Issue
3
Pages
787-795
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2111840256
Cited by
168
References
2
FWCI
4.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. https://app.cochat.ai/papers/10.1002/hep.1840210328
The paper
Takahara, T., Furui, K., Funaki, J., Nakayama, Y., Itoh, H., Miyabayashi, C., Sato, H., Seiki, M., Ooshima, A., & Watanabe, A. (1995). Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology. https://doi.org/10.1002/hep.1840210328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.